A new study suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI). By studying the effects of the nasal anti-CD3 in a ...
The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in ...
The asthma medication reduces congestion in patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps in a ...
Could football players with a concussion one day be treated with a quick spray up their nose? That could be a possibility one day after a new study found that a monoclonal antibody-based nasal ...
14d
News Medical on MSNNasal spray may offer new hope for traumatic brain injury patientsA new study led by researchers at Mass General Brigham suggests a nasal spray developed to target neuroinflammation could one day be an effective treatment for traumatic brain injury (TBI).
4d
The Brighterside of News on MSNNew nighttime nasal spray significantly alleviates sleep apneaA nighttime nasal spray may offer a new way to ease sleep apnea and lower blood pressure, according to Australian researchers ...
WGNO-TV New Orleans on MSN8d
Nasal spray recalled nationwide; risk of infection: FDA(WHTM) — The U.S. Food & Drug Administration (FDA) has announced the voluntary recall of a sinus nasal wash bottle system following a confirmed test result of microbial contamination. According to the ...
A Mass General Brigham-led study in preclinical models suggests that a nasal spray being tested for use in preventing Alzheimer’s disease could also reduce neuroinflammation in traumatic brain ...
The FDA has approved Neffy, a needle-free nasal spray, for children aged 4 and up, providing fast and effective treatment for severe allergic reactions and anaphylaxis.
23h
KHQA on MSNBlessing Health introduces new FDA-approved nasal spray treatment for resistant depressionUp to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck’
In December, retired electrician Joe Walsh, 79, became the first Alzheimer’s patient to try a nasal spray used to treat other neurological diseases. Walsh, of Quincy, started having trouble ...
The FDA recently announced a voluntary recall of a popular Sinu Cleanse nasal spray sold at retailers like H-E-B, Walgreens, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results